Russian vaccines against coronavirus are in demand abroad, it is important to continue the transfer of technologies to foreign sites. This was announced on Friday, December 25, by Prime Minister Mikhail Mishustin.
“Of course, it is not enough just to share your competencies, you need to receive, among other things, feedback from foreign colleagues, to do appropriate collaborations. Today this work is being carried out literally online, “he said at a meeting with manufacturers of vaccines against COVID-19.
At the same time, the prime minister urged to increase production capacity. “Through joint efforts, we also need to scale up production. Today we will discuss how this work is going, ”added Mishustin.
Earlier during the meeting, the Prime Minister announced that about 6.5 million doses of the Sputnik V vaccine will be delivered to hospitals during January and February 2021. According to him, the plans for the production of drugs are being overfulfilled.
Also on the same day, Mishustin promised that the Russian authorities will continue to provide support to companies producing vaccines against coronavirus infection.
Large-scale vaccination in all regions of the country started on December 15. Citizens are injected with a drug developed by specialists from the Sputnik V Gamaleya Center. It became the first coronavirus vaccine in Russia and in the world, which was registered on August 11. The registration of the vaccine of the “Vector” center became known on October 14, the drug was named “EpiVacCorona”.
All relevant information on the situation with the coronavirus is available on the websites of stopcoronavirus.rf and access to all.rf, as well as by the hashtag #WeVotre. Coronavirus hotline: 8 (800) 2000-112.